Alligator Bioscience Granted US Patent Covering ATOR-4066 Bispecific Antibody
LUND, SE / ACCESS Newswire / October 21, 2025 / Alligator Bioscience (Nasdaq Stockholm: ATORX)(STO:ATORX), a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs, today announced that the United States Patent and Trademark Office (USPTO) has granted US Patent No. 12,448,465, covering the composition of matter of ATOR-4066, the company’s bispecific antibody targeting CD40 and […]